Table 1. Characteristics of 230 toxoplasmic retinochoroiditis patients, Rio de Janeiro, July 2015.
| Recurrences during follow-up | Yes (N = 104) | No (N = 126) | ||||
|---|---|---|---|---|---|---|
| n | % | 95% CI | N | % | 95% CI | |
| Sex | ||||||
| Female | 51 | 49.0 | 39.10–59.03 | 61 | 48.4 | 39.41–57.49 |
| Male | 53 | 50.9 | 40.97–60.90 | 65 | 51.6 | 42.51–60.59 |
| Toxoplasmosis serology | ||||||
| Only IgG | 93 | 89.4 | 81.87–94.60 | 116 | 92.1 | 85.89–96.12 |
| IgG and IgM | 11 | 10.6 | 5.40–18.13 | 10 | 7.9 | 3.88–14.11 |
| Number of retinochoroidal lesions | ||||||
| Primary lesion | 33 | 31.7 | 22.94–41.59 | 19 | 15.1 | 9.32–22.54 |
| Recurrent lesion (2 or more) |
71 | 68.3 | 58.41–77.05 | 107 | 84.9 | 77.46–90.68 |
| IFN-γ +874 gene polymorphism | ||||||
| AA | 35 | 33.6 | 24.69–43.59 | 64 | 50.8 | 41.73–59.81 |
| AT | 50 | 48.1 | 38.18–58.09 | 41 | 32.5 | 24.47–41.45 |
| TT | 19 | 18.3 | 11.38–27.05 | 21 | 16.7 | 10.62–24.34 |